A detailed history of Norwood Financial Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Norwood Financial Corp holds 50 shares of LLY stock, worth $38,819. This represents 0.06% of its overall portfolio holdings.

Number of Shares
50
Previous 70 28.57%
Holding current value
$38,819
Previous $40,000 5.0%
% of portfolio
0.06%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$592.2 - $792.28 $11,844 - $15,845
-20 Reduced 28.57%
50 $38,000
Q3 2023

Oct 16, 2023

SELL
$434.7 - $599.3 $54,337 - $74,912
-125 Reduced 64.1%
70 $37,000
Q2 2023

Jul 27, 2023

SELL
$350.74 - $468.98 $7,014 - $9,379
-20 Reduced 9.3%
195 $91,000
Q1 2023

Apr 25, 2023

SELL
$310.63 - $364.82 $12,425 - $14,592
-40 Reduced 15.69%
215 $73,000
Q4 2021

Feb 08, 2022

BUY
$224.85 - $279.04 $57,336 - $71,155
255 New
255 $70,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $738B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Norwood Financial Corp Portfolio

Follow Norwood Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norwood Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Norwood Financial Corp with notifications on news.